---
content_type: page
description: 'This section provides the list of required and recommended readings
  for each session of the course. '
draft: false
learning_resource_types:
- Readings
ocw_type: CourseSection
title: Readings
uid: 2947c805-f872-6255-a8f2-ca8b8a286944
---
{{< tableopen >}}{{< theadopen >}}{{< tropen >}}{{< thopen >}}
SES #
{{< thclose >}}{{< thopen >}}
TOPICS
{{< thclose >}}{{< thopen >}}
READINGS
{{< thclose >}}{{< trclose >}}{{< theadclose >}}{{< tbodyopen >}}{{< tropen >}}{{< tdopen >}}
1
{{< tdclose >}}{{< tdopen >}}
Introduction From Discovery to Market: An Integrated View
{{< tdclose >}}{{< tdopen >}}

### Required

Jack, Andrew. "{{% resource_link "610f7230-1401-4b7b-aa65-f555be23fc64" "Pharmaceuticals: Back to the Lab" %}}," *Financial Times*, August 10, 2013.

Munos, B. "{{% resource_link "e180ea9f-62ff-4d65-b233-5e084ce74c8d" "Lessons from 60 Years of Pharmaceutical Innovation" %}}." *Nature Reviews Drug Discovery* 8 (2009): 959–68.

U.S. Food and Drug Administration. {{% resource_link "08dd7f23-3c8e-4831-952c-4b2bd6dc5b61" "\"FY 2011 Innovative Drug Approvals.\" (PDF - 5.0MB)" %}} U.S. Department of Health and Human Services, U.S. Food and Drug Administration.

{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
2
{{< tdclose >}}{{< tdopen >}}
Brief Economic History of the Pharmaceutical Industry
{{< tdclose >}}{{< tdopen >}}

### Required

Rang, H. P., ed. Chapters 1–3 in *Drug Discovery and Development: Technology in Transition*. Churchill Livingstone, 2006, pp. 3–40. ISBN: 9780443064203.

Saftlas, Herman. "Healthcare: Pharmaceuticals." *Standard & Poor's Industry Surveys*. June 4, 2009. *S&P Net Advantage*.

U.S. Food and Drug Administration. {{% resource_link "ddc2163b-cfd3-40d9-af61-c0052b75a21d" "\"FY 2011 Innovative Drug Approvals.\" (PDF - 5.0MB)" %}} U.S. Department of Health and Human Services, U.S. Food and Drug Administration.

{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
3
{{< tdclose >}}{{< tdopen >}}
The Pharmaceutical Industry and the Drug Development Process; Basic Science
{{< tdclose >}}{{< tdopen >}}
No Readings
{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
4
{{< tdclose >}}{{< tdopen >}}
Business of Biopharmaceuticals
{{< tdclose >}}{{< tdopen >}}

### Required

Silver, Steven. "Healthcare: Pharmaceuticals." *Standard & Poor's Industry Surveys*. August 13, 2009. *S&P Net Advantage*.

Lawrence, Stacy. "{{% resource_link "d53574b3-d7c1-474e-a295-a1a43078e486" "Looking for an Oasis" %}}." *BioCentury, The Bernstein Report on Biobusiness* 16, no. 3 (2008): A1–A10.

Johnson, Avery. "{{% resource_link "7831c0ed-ee3d-42eb-b634-523b96e29a04" "As Drug Industry Struggles, Chemists Face Layoff Wave" %}}," *Wall Street Journal*, December 11, 2007.

Martinez, Barbara. "{{% resource_link "35f2f49a-8bb8-42f5-9fbd-d40e77846ec8" "Big Pharma Faces Grim Prognosis: Industry Fails to Find New Drugs to Replace Wonders Like Lipitor" %}}," *Wall Street Journal*, December 6, 2007.

Silberman, Steve. "{{% resource_link "2a087beb-5ccb-4aba-bb48-931e13f5df1a" "Placebos are Getting More Effective. Drugmakers are Desperate to Know Why" %}}." *Wired Magazine* 17.09, August 2009.

### Recommended

{{% resource_link "9e5b1381-6869-472e-bad3-5b78615dfcba" "Merck & Schering-Plough Merger Investor Presentation (PDF)" %}} March 9, 2009. Merck Schering-Plough.

Schoeberl, B., E. A. Pace, et al. "{{% resource_link "b713e62a-c86f-48f8-b1e3-dd8adcde3ec5" "Therapeutically Targeting ErbB3: A Key Node in Ligand-Induced Activation of the ErbB Receptor–PI3K Axis" %}}." *Science Signaling* 77, no. 2 (2009): ra31.

{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
5
{{< tdclose >}}{{< tdopen >}}
Accelerating Cancer Cures: A Global Frontier
{{< tdclose >}}{{< tdopen >}}
Skloot, Rebecca. "{{% resource_link "d9cba2e7-3c7f-4335-bec6-18a4d7054167" "*About The Immortal Life of Henrietta Lacks*" %}}."
{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
6
{{< tdclose >}}{{< tdopen >}}
Clinical Drug Development
{{< tdclose >}}{{< tdopen >}}
Burton, Thomas M. "{{% resource_link "de9cc828-41ba-4ce8-aac2-4b6eb3823630" "By Learning from Failures, Lilly Keeps Drug Pipeline Full" %}}," *Wall Street Journal*, April 21, 2004.
{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
7
{{< tdclose >}}{{< tdopen >}}
Drug Delivery Systems
{{< tdclose >}}{{< tdopen >}}

### Recommended

Alves, S., E. Régulier, et al. "{{% resource_link "aa73c64c-3c84-48ff-b0d0-a79a820f03c9" "Striatal and Nigral Pathology in a Lentiviral Rat Model of Machado-Joseph Disease" %}}." *Human Molecular Genetics* 17, no. 14 (2008): 2071–83.

Moreira, J. N., A. Santos, et al. "{{% resource_link "f929e6ed-fa2d-4c04-a210-268da9c617cb" "Non-Viral Lipid-Based Nanoparticles for Targeted Cancer Systemic Gene Silencing" %}}." *Journal of Nanoscience and Nanotechnology* 8, no. 18 (2008): 2187–204.

{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
8–10
{{< tdclose >}}{{< tdopen >}}

Regulation

Emerging Pharmaceutical Science and Technology I

Manufacturing I

Reimbursement

Emerging Pharmaceutical Science and Technology II

{{< tdclose >}}{{< tdopen >}}

### Required

Rubin, L. "{{% resource_link "7cdf6e7d-bfae-4915-a7e5-70cb08678497" "Stem Cells and Drug Discovery: The Beginning of a New Era?" %}}" *Cell* 132 (2008): 549–52.

### Recommended

Radley, D. C., S. N. Finkelstein, et al. "{{% resource_link "4fd42747-a876-46f5-ad9d-8602f1dff809" "Off-label Prescribing Among Office-based Physicians" %}}." *Archives of Internal Medicine* 166 no. 9 (2006): 1021–26.

Rubin, L., and F. J. de Sauvage. "{{% resource_link "6d9af16e-c984-4511-af9e-bc68c1fcde50" "Targeting the Hedgehog Pathway in Cancer" %}}." *Nature Reviews Drug Discovery* 5, no. 12 (2006): 1026–33.

{{% resource_link "2665e02a-471d-4679-b74b-de822d5a4c79" "*The Burrill Report*" %}} 3, no. 9 (2013).

Jones, Matt. "GenomeWeb Feature: Slow, Steady Decline in NIH Funding Leads Researchers to Fear Future Cuts," *GenomeWeb Daily News*, July 18, 2013.

Philippidis, Alex. "{{% resource_link "0e16b1f9-600b-43b1-8dca-eccbcc5a781f" "Researchers Chafe as NIH Budgets Shrivel" %}}," *Genetic Engineering & Biotechnology News*, September 13, 2013.

"{{% resource_link "4a75a148-8d1b-4fb3-b250-8e7f8c9cbe60" "As VC Falters, Early-stage Biotechs Look Elsewhere for Cash" %}}," *FierceBiotech*, October 21, 2013.

"Universities Stepping Up Efforts To Discover Drugs," *Forbes*, October 21, 2013.

{{< tdclose >}}{{< trclose >}}{{< tropen >}}{{< tdopen >}}
11–13
{{< tdclose >}}{{< tdopen >}}

Manufacturing II

Manufacturing III

Student Presentations

{{< tdclose >}}{{< tdopen >}}

### Required

Thayer, A. M. "{{% resource_link "7717026a-f1ac-4bed-ac20-f3f3ac30794f" "The New Copycats" %}}." *Chemical & Engineering News* 91, no. 40 (2013): 15–23.

Wechsler, J. "{{% resource_link "48e5c726-6887-46c8-be4c-c0a11887f021" "Drug Quality at Center Stage for FDA and Manufacturers" %}}." *BioPharm International* 26, no. 1 (2013): 10–12.

Kozlowski, S., J. Woodcock, et al. "{{% resource_link "8e2e08fc-d32c-4d3f-8013-fc2fa61bfbb7" "Developing the Nation's Biosimilars Program" %}}." *The New England Journal of Medicine* 365, no. 5 (2011): 385–88.

Thomas, Katie. "{{% resource_link "02658368-0d64-492b-9651-da3dd276b335" "Lapses at Big Drug Factories Add to Shortages and Danger" %}}," *New York Times*, October 17, 2012.

Basu, P., G. Joglekar, et al. "{{% resource_link "97454e9c-a439-4bae-a7dd-c1838dddeac3" "Analysis of Manufacturing Costs in Pharmaceutical Companies" %}}." *Journal of Pharmaceutical Innovation* 3, no. 1 (2008): 30–40.

{{% resource_link "0c4bf3b2-8e0e-4dac-acb0-edba0a7098e7" "\"Quality Manufacturing: A Blockbuster Opportunity for Pharmaceuticals, An Economist Intelligence Unit White Paper Written in Co-operation with Oracle.\" (PDF)" %}} *Economist Intelligence Unit, The Economist*, September 2005.

"{{% resource_link "2e9c12f9-120e-469f-b475-60fd0781458e" "Business: Trouble in the Making; Pharmaceuticals" %}}." *The Economist* 364, no. 8288 (2002).

### Recommended

{{% resource_link "6c1f423d-b6cd-4b69-a63b-13bb21724a12" "\"Guidance for Industry Q8(R2) Pharmaceutical Development.\" (PDF)" %}} ICH Revision 2. U.S. Department of Health and Human Services, Food and Drug Administration, November 2009.

{{% resource_link "18d0dc45-8bd4-47e3-aa29-9a864d019770" "\"Guidance for Industry Q10 Pharmaceutical Quality System.\" (PDF)" %}} ICH. U.S. Department of Health and Human Services, Food and Drug Administration, April 2009.

{{< tdclose >}}{{< trclose >}}{{< tbodyclose >}}{{< tableclose >}}